Preclinical Evaluation of the Antifolate QN254, 5-Chloro- N′6′-(2,5-Dimethoxy-Benzyl)-Quinazoline-2,4,6-Triamine, as an Antimalarial Drug Candidate

MLA

Nzila, Alexis, et al. “Preclinical Evaluation of the Antifolate QN254, 5-Chloro- N′6′-(2,5-Dimethoxy-Benzyl)-Quinazoline-2,4,6-Triamine, as an Antimalarial Drug Candidate.” Antimicrobial Agents and Chemotherapy, vol. 54, no. 6, June 2010, pp. 2603–10. EBSCOhost, https://doi.org/10.1128/AAC.01526-09.

APA

Nzila, A., Rottmann, M., Chitnumsub, P., Kiara, S. M., Kamchonwongpaisan, S., Maneeruttanarungroj, C., Taweechai, S., Yeung, B. K. S., Goh, A., Lakshminarayana, S. B., Zou, B., Wong, J., Ma, N. L., Weaver, M., Keller, T. H., Dartois, V., Wittlin, S., Brun, R., Yuthavong, Y., & Diagana, T. T. (2010). Preclinical Evaluation of the Antifolate QN254, 5-Chloro- N′6′-(2,5-Dimethoxy-Benzyl)-Quinazoline-2,4,6-Triamine, as an Antimalarial Drug Candidate. Antimicrobial Agents and Chemotherapy, 54(6), 2603–2610. https://doi.org/10.1128/AAC.01526-09

Chicago

Nzila, Alexis, Matthias Rottmann, Penchit Chitnumsub, Stevens M. Kiara, Sumalee Kamchonwongpaisan, Cherdsak Maneeruttanarungroj, Supannee Taweechai, et al. 2010. “Preclinical Evaluation of the Antifolate QN254, 5-Chloro- N′6′-(2,5-Dimethoxy-Benzyl)-Quinazoline-2,4,6-Triamine, as an Antimalarial Drug Candidate.” Antimicrobial Agents and Chemotherapy 54 (6): 2603–10. doi:10.1128/AAC.01526-09.